GlassScriptPhysician profile
Meryl S Logan
NPI 1730513482
$10,234.98
in general payments reported to CMS, 2019-2025
12 companies · $3,355 in 2025
The $3,355 reported for 2025 was more than what 79% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2021: $138 · 2023: $426 · 2024: $5,860 · 2025: $3,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,135 · Food and Beverage: $2,831 · Travel and Lodging: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,134.50 |
| Food and Beverage | $2,831.42 |
| Travel and Lodging | $675.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $4,493.13 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Iliac Branch Endoprosthesis, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Vascular Technology, INC. | $2,134.50 | 2025 | |
| Inari Medical, INC. | $951.70 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $735.54 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $567.71 | 2019-2025 | General - Vascular Intervention, Wallstent Rp Endoprosthesis, Eluvia |
| Penumbra, INC. | $442.99 | 2024-2025 | Penumbra System |
| Medtronic Vascular, INC. | $338.75 | 2019 | |
| Medtronic, INC. | $286.54 | 2021-2024 | Endurant Iis |
| Surmodics, INC. | $178.26 | 2024-2025 | Pounce Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System |
| Lemaitre Vascular, INC. | $46.37 | 2025 | Artegraft Vascular Graft |
| Reflow Medical INC | $44.15 | 2025 | |
| Dilon Technologies, INC. | $15.34 | 2025 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meryl Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.